44
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Hairy Cell Leukemia-Variant with Cladribine

, &
Pages 347-354 | Received 20 Feb 1999, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Robert J. Kreitman. (2019) Hairy cell leukemia: present and future directions. Leukemia & Lymphoma 60:12, pages 2869-2879.
Read now
Tadeusz Robak. (2008) Emerging drugs for rarer chronic lymphoid leukemias. Expert Opinion on Emerging Drugs 13:1, pages 95-118.
Read now
Natalya Greyz & Alan Saven. (2004) Cladribine: from the bench to the bedside – focus on hairy cell leukemia. Expert Review of Anticancer Therapy 4:5, pages 745-757.
Read now

Articles from other publishers (28)

Robert J. Kreitman & Evgeny Arons. (2022) Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. Blood Reviews 51, pages 100888.
Crossref
Dai Chihara, Evgeny AronsMaryalice Stetler-StevensonConstance Yuan, Hao-Wei WangHong ZhouMark RaffeldLiqiang Xi, Seth M. Steinberg, Julie FeurtadoLacey James-EcheniqueChin-Hsien Tai, Keyur P. Patel, Raul C. Braylan, Katherine R. Calvo, Irina Maric, Alina Dulau-Florea & Robert J. Kreitman. (2021) Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant. Blood Advances 5:23, pages 4807-4816.
Crossref
Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 301 427 .
Naoto Imoto, Daisuke Koyama, Isamu Sugiura & Shingo Kurahashi. (2021) Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant. Medicine 100:5, pages e24457.
Crossref
Tadeusz Robak & Sascha Dietrich. 2021. Indolent Lymphomas. Indolent Lymphomas 179 194 .
Fengming Huang, Cong Zhang, Qiang Liu, Yan Zhao, Yuqing Zhang, Yuhao Qin, Xiao Li, Chang Li, Congzhao Zhou, Ningyi Jin & Chengyu Jiang. (2020) Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury. PLOS Pathogens 16:3, pages e1008341.
Crossref
Paul Letendre & Donald Doll. (2018) Novel therapeutics in the treatment of hairy cell leukemia variant. Leukemia Research 75, pages 58-60.
Crossref
Philip A. Thompson & Farhad Ravandi. (2017) How I manage patients with hairy cell leukaemia. British Journal of Haematology 177:4, pages 543-556.
Crossref
Dharmendra Jain, Pranav Dorwal, Smeeta Gajendra, Amit Pande, Simmi Mehra & Ritesh Sachdev. (2016) CD5 positive hairy cell leukemia: A rare case report with brief review of literature. Cytometry Part B: Clinical Cytometry 90:5, pages 467-472.
Crossref
Robert J. Kreitman, Wyndham Wilson, Katherine R. Calvo, Evgeny Arons, Laura Roth, Jeffrey Sapolsky, Hong Zhou, Mark Raffeld & Maryalice Stetler-Stevenson. (2013) Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia. Clinical Cancer Research 19:24, pages 6873-6881.
Crossref
Robert J. Kreitman. (2013) Hairy Cell Leukemia—New Genes, New Targets. Current Hematologic Malignancy Reports 8:3, pages 184-195.
Crossref
Claudio Ortolani. 2011. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 160 300 .
Kevin T. Kim, Darren S. Sigal & Alan Saven. 2011. Advances in Malignant Hematology. Advances in Malignant Hematology 253 265 .
Tadeusz Robak. (2011) Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment. Cancer Treatment Reviews 37:1, pages 3-10.
Crossref
Darren S. Sigal & Alan Saven. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 116 130 .
Evgeny Arons, Tara Suntum, Maryalice Stetler-Stevenson & Robert J. Kreitman. (2009) VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood 114:21, pages 4687-4695.
Crossref
Henry Y. Dong, James Weisberger, Zach Liu & Sorina Tugulea. (2009) Immunophenotypic Analysis of CD103+ B-Lymphoproliferative Disorders. American Journal of Clinical Pathology 131:4, pages 586-595.
Crossref
Graça M. Dores, Rayna K. Matsuno, Dennis D. Weisenburger, Philip S. Rosenberg & William F. Anderson. (2008) Hairy cell leukaemia: a heterogeneous disease?. British Journal of Haematology 142:1, pages 45-51.
Crossref
Patricia Martín-Jiménez, Ramón García-Sanz, David González, Ana Balanzategui, José J. Pérez, M. Dolores Caballero, M. Eugenia Sarasquete, Josefina Galende, Alberto Orfao, M. Consuelo López-Berges, Jesús F. San Miguel & Marcos González. (2007) Molecular Characterization of Complete and Incomplete Immunoglobulin Heavy Chain Gene Rearrangements in Hairy Cell Leukemia. Clinical Lymphoma and Myeloma 7:9, pages 573-579.
Crossref
Ronan Swords & Francis Giles. (2007) Hairy cell leukemia. Medical Oncology 24:1, pages 7-15.
Crossref
Robert W. Sharpe & Kelly J. Bethel. (2006) Hairy Cell Leukemia: Diagnostic Pathology. Hematology/Oncology Clinics of North America 20:5, pages 1023-1049.
Crossref
Tadeusz Robak. (2006) Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treatment Reviews 32:5, pages 365-376.
Crossref
Charin Ya-In, Joseph Brandwein, Dominic Pantalony & Hong Chang. (2005) Hairy Cell Leukemia Variant With Features of Intrasinusoidal Bone Marrow Involvement. Archives of Pathology & Laboratory Medicine 129:3, pages 395-398.
Crossref
Melissa H. Cessna, Leah Hartung, Sheryl Tripp, Sherrie L. Perkins & David W. Bahler. (2005) Hairy Cell Leukemia Variant. American Journal of Clinical Pathology 123:1, pages 132-138.
Crossref
Nadine P. Kelly, Serhan Alkan & Sucha Nand. (2003) Hairy Cell Leukemia Variant Developing in a Background of Polycythemia Vera. Archives of Pathology & Laboratory Medicine 127:4, pages e209-e211.
Crossref
D.J Allsup & J.C Cawley. (2002) The diagnosis and treatment of hairy-cell leukaemia. Blood Reviews 16:4, pages 255-262.
Crossref
Robert J. Kreitman. (2002) Hairy Cell Leukemia. American Journal of Cancer 1:3, pages 189-203.
Crossref
. (2001) Treatment of Hairy-Cell Leukemia. New England Journal of Medicine 345:20, pages 1500-1501.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.